FI991477A0 - Menetelmä tolterodiinin valmistamiseksi - Google Patents
Menetelmä tolterodiinin valmistamiseksiInfo
- Publication number
- FI991477A0 FI991477A0 FI991477A FI991477A FI991477A0 FI 991477 A0 FI991477 A0 FI 991477A0 FI 991477 A FI991477 A FI 991477A FI 991477 A FI991477 A FI 991477A FI 991477 A0 FI991477 A0 FI 991477A0
- Authority
- FI
- Finland
- Prior art keywords
- tolterodine
- preparation
- benzopyran
- dihydro
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Optical Integrated Circuits (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3396196P | 1996-12-31 | 1996-12-31 | |
PCT/US1997/022521 WO1998029402A1 (en) | 1996-12-31 | 1997-12-18 | Process to prepare tolterodine |
Publications (2)
Publication Number | Publication Date |
---|---|
FI991477A0 true FI991477A0 (fi) | 1999-06-29 |
FI991477A FI991477A (fi) | 1999-06-29 |
Family
ID=21873473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI991477A FI991477A (fi) | 1996-12-31 | 1999-06-29 | Menetelmä tolterodiinin valmistamiseksi |
Country Status (23)
Country | Link |
---|---|
US (1) | US5922914A (ko) |
EP (1) | EP0960109B1 (ko) |
JP (1) | JP4199310B2 (ko) |
KR (2) | KR20000057548A (ko) |
CN (1) | CN1151141C (ko) |
AT (1) | ATE226949T1 (ko) |
AU (1) | AU717985B2 (ko) |
CA (1) | CA2273789C (ko) |
CZ (1) | CZ295477B6 (ko) |
DE (1) | DE69716767T2 (ko) |
DK (1) | DK0960109T3 (ko) |
ES (1) | ES2186018T3 (ko) |
FI (1) | FI991477A (ko) |
HK (1) | HK1023566A1 (ko) |
HU (1) | HUP0000527A3 (ko) |
NO (1) | NO317158B1 (ko) |
NZ (1) | NZ336533A (ko) |
PL (1) | PL191603B1 (ko) |
PT (1) | PT960109E (ko) |
RU (1) | RU2176246C2 (ko) |
SI (1) | SI0960109T1 (ko) |
SK (1) | SK283591B6 (ko) |
WO (1) | WO1998029402A1 (ko) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000515525A (ja) * | 1996-07-19 | 2000-11-21 | アベーグ,グンナー | 尿と胃腸の疾患の治療におけるs(―)―トルテロジン |
EP0957073A1 (en) * | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
ATE305307T1 (de) | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | Reboxetin zur behandlung von migränekopfschmerzen |
US6566537B2 (en) | 1999-12-30 | 2003-05-20 | Pharmacia Ab | Process and intermediates |
SE9904850D0 (sv) * | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
DE10033016A1 (de) * | 2000-07-07 | 2002-01-24 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen |
PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
US20030027856A1 (en) * | 2001-06-29 | 2003-02-06 | Aberg A.K. Gunnar | Tolterodine metabolites |
IN191835B (ko) | 2001-08-03 | 2004-01-10 | Ranbaxy Lab Ltd | |
MXPA04003865A (es) * | 2001-10-26 | 2004-07-08 | Upjohn Co | Compuestos de amonio cuaternario y sus usos como agentes antimuscarinicos. |
US7005449B2 (en) * | 2002-04-23 | 2006-02-28 | Pharmacia & Upjohn Company | Tolterodine salts |
CN1668585A (zh) | 2002-07-08 | 2005-09-14 | 兰贝克赛实验室有限公司 | 用作蝇蕈碱受体拮抗剂的3,6-二取代氮杂双环[3.1.0]己烷衍生物 |
US7265147B2 (en) | 2002-07-31 | 2007-09-04 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
US7410993B2 (en) | 2002-08-09 | 2008-08-12 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists |
US7288562B2 (en) | 2002-08-23 | 2007-10-30 | Ranbaxy Laboratories Limited | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
WO2004019925A1 (en) * | 2002-08-28 | 2004-03-11 | Pharmacia Corporation | Oral liquid tolterodine composition |
JP2006518707A (ja) | 2002-12-10 | 2006-08-17 | ランバクシー ラボラトリーズ リミテッド | ムスカリン様受容体アンタゴニストとしての3,6−二置換アザビシクロ[3.1.0]ヘキサン誘導体 |
ATE386738T1 (de) | 2002-12-23 | 2008-03-15 | Ranbaxy Lab Ltd | Flavaxat-derivate als muscarin-rezeptor antagonisten |
WO2004056767A1 (en) | 2002-12-23 | 2004-07-08 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
CA2517824A1 (en) * | 2003-03-06 | 2004-09-16 | Neela Praveen Kumar | 3,3-diarylpropylamine derivatives and processes for isolation thereof |
WO2004089281A2 (en) * | 2003-04-08 | 2004-10-21 | Hetero Drugs Limited | Novel polymorphs of tolterodine tartrate |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
AU2003214520A1 (en) | 2003-04-09 | 2004-11-01 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
EP1615887A1 (en) | 2003-04-10 | 2006-01-18 | Ranbaxy Laboratories, Ltd. | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
AU2003214535B2 (en) | 2003-04-10 | 2009-09-03 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
WO2004089900A1 (en) | 2003-04-11 | 2004-10-21 | Ranbaxy Laboratories Limited | Azabicyclo derivatives as muscarinic receptor antagonists |
ITMI20031354A1 (it) * | 2003-07-02 | 2005-01-03 | Istituto Di Chimica Biomolecolare D El Cnr Sezione | Sintesis enantioselettiva di composti enantiomericamente arricchiti. |
ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
EP1701932B1 (en) * | 2003-12-24 | 2012-07-18 | Cipla Ltd. | Tolterodine, compositions and uses thereof, and preparation of the same |
EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
ITMI20041920A1 (it) * | 2004-10-11 | 2005-01-11 | Chemi Spa | Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina |
US7355077B2 (en) * | 2004-10-28 | 2008-04-08 | Dr. Reddy's Laboratories Limited | Process for preparing tolterodine |
JP4513535B2 (ja) * | 2004-12-03 | 2010-07-28 | 住友化学株式会社 | トルテロジンの製造方法 |
TW200637804A (en) * | 2005-01-10 | 2006-11-01 | Teva Pharma | Substantially pure tolterodine tartrate and process for preparing thereof |
US7528267B2 (en) | 2005-08-01 | 2009-05-05 | Girindus America, Inc. | Method for enantioselective hydrogenation of chromenes |
ES2268987B1 (es) | 2005-08-05 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de 3,3-difenilpropilaminas. |
WO2007039918A1 (en) * | 2005-10-06 | 2007-04-12 | Natco Pharma Limited | Novel process for the preparation of tolterodine |
JP2009512676A (ja) | 2005-10-19 | 2009-03-26 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性受容体アンタゴニストの医薬組成物 |
KR100686351B1 (ko) * | 2006-01-12 | 2007-02-22 | 주식회사 카이로제닉스 | 톨테로딘 라세미체의 제조방법 |
ITMI20060110A1 (it) * | 2006-01-24 | 2007-07-25 | Dipharma Spa | Procedimento per la purificazione di tolterodina |
DK2029567T3 (da) * | 2006-05-24 | 2010-11-29 | Pfizer Ltd | Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater |
US7268257B1 (en) | 2006-05-31 | 2007-09-11 | Sumitomo Chemical Company, Limited | Process for producing tolterodine |
CZ302585B6 (cs) * | 2007-02-26 | 2011-07-20 | Zentiva, A. S. | Krystalická sul 2-[(1R)-3-[bis(1-methylethyl)amino]-1-fenylpropyl]-4-methylfenolu s kyselinou (2R,3R)-2,3-dihydroxybutandiovou |
US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
KR101188333B1 (ko) * | 2008-02-20 | 2012-10-09 | 에스케이케미칼주식회사 | 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염 |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
ITMI20082055A1 (it) * | 2008-11-19 | 2009-02-18 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-tolterodina base libera |
WO2010092500A2 (en) | 2009-02-12 | 2010-08-19 | Alembic Limited | A process for the preparation of tolterodine tartrate |
EP2398765A1 (en) * | 2009-02-17 | 2011-12-28 | Pharmathen S.A. | Improved process for the preparation of (r)-2-(3-diisopropylamino)-1-phenylpropyl)-4methylphenol and salts thereof |
WO2011125763A1 (ja) | 2010-03-31 | 2011-10-13 | 小野薬品工業株式会社 | 手足症候群の予防および/または治療剤 |
WO2012098044A1 (en) | 2011-01-17 | 2012-07-26 | Cambrex Profarmaco Milano S.R.L. | Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate |
EP2476665A1 (en) | 2011-01-17 | 2012-07-18 | Cambrex Profarmaco Milano S.r.l. | Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate |
CN102516098B (zh) * | 2011-12-09 | 2014-06-18 | 北京联本医药化学技术有限公司 | 酒石酸托特罗定制备方法 |
CN103044274B (zh) * | 2012-11-29 | 2014-10-22 | 珠海保税区丽珠合成制药有限公司 | 一种无溶剂合成酒石酸托特罗定的方法 |
GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
CN110229072B (zh) * | 2019-06-25 | 2022-04-08 | 中国药科大学 | 一种托特罗定及其对映体的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8800207D0 (sv) * | 1988-01-22 | 1988-01-22 | Kabivitrum Ab | Nya aminer, deras anvendning och framstellning |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
NO179904C (no) * | 1992-09-04 | 1997-01-08 | Takeda Chemical Industries Ltd | Kondenserte heterocykliske forbindelser og deres anvendelse |
-
1997
- 1997-11-21 KR KR1019990705269A patent/KR20000057548A/ko not_active Application Discontinuation
- 1997-12-18 US US08/993,257 patent/US5922914A/en not_active Expired - Lifetime
- 1997-12-18 WO PCT/US1997/022521 patent/WO1998029402A1/en active IP Right Grant
- 1997-12-18 DK DK97954678T patent/DK0960109T3/da active
- 1997-12-18 NZ NZ336533A patent/NZ336533A/xx not_active IP Right Cessation
- 1997-12-18 CA CA002273789A patent/CA2273789C/en not_active Expired - Fee Related
- 1997-12-18 SI SI9730426T patent/SI0960109T1/xx unknown
- 1997-12-18 DE DE69716767T patent/DE69716767T2/de not_active Expired - Lifetime
- 1997-12-18 PL PL334375A patent/PL191603B1/pl not_active IP Right Cessation
- 1997-12-18 ES ES97954678T patent/ES2186018T3/es not_active Expired - Lifetime
- 1997-12-18 AT AT97954678T patent/ATE226949T1/de active
- 1997-12-18 HU HU0000527A patent/HUP0000527A3/hu unknown
- 1997-12-18 JP JP53003098A patent/JP4199310B2/ja not_active Expired - Fee Related
- 1997-12-18 RU RU99116356/04A patent/RU2176246C2/ru not_active IP Right Cessation
- 1997-12-18 AU AU59569/98A patent/AU717985B2/en not_active Ceased
- 1997-12-18 SK SK815-99A patent/SK283591B6/sk not_active IP Right Cessation
- 1997-12-18 CN CNB971801479A patent/CN1151141C/zh not_active Expired - Fee Related
- 1997-12-18 KR KR10-1999-7005910A patent/KR100463614B1/ko not_active IP Right Cessation
- 1997-12-18 PT PT97954678T patent/PT960109E/pt unknown
- 1997-12-18 EP EP97954678A patent/EP0960109B1/en not_active Expired - Lifetime
- 1997-12-18 CZ CZ19992272A patent/CZ295477B6/cs not_active IP Right Cessation
-
1999
- 1999-06-29 FI FI991477A patent/FI991477A/fi unknown
- 1999-06-29 NO NO19993247A patent/NO317158B1/no not_active IP Right Cessation
-
2000
- 2000-04-28 HK HK00102580A patent/HK1023566A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI991477A0 (fi) | Menetelmä tolterodiinin valmistamiseksi | |
EA199700170A1 (ru) | Способ получения некоторых азациклогексапетидов | |
NO20016226D0 (no) | Fremgangsmåte for fremstilling av substituerte formamider | |
NO975387D0 (no) | Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler | |
NO981800L (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
BG104117A (en) | Universally applicable blood plasma | |
HUP9900935A2 (hu) | Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására | |
ES2122905A1 (es) | Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato). | |
AU2895397A (en) | Novel substance library and supramolecular complexes prepared therewith | |
ES2015432A6 (es) | Metodo de preparacion de 2', 3'-dideoxi-nucleosidos. | |
MX9706744A (es) | Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol. | |
AU624962B2 (en) | Ghilanten: antimetastatic principle from the south american leech, haementeria ghilanii | |
DE69702961D1 (de) | Herstellung von 1,1-difluorethan | |
IL135516A0 (en) | Process for n-desmethylating erythromycins and derivatives thereof | |
SE8504409D0 (sv) | Novel chemical intermediates | |
RU1808895C (ru) | Напорна сортировка | |
SU1220180A1 (ru) | Установка для массообмена | |
ZA966542B (en) | Process for the preparation of 3,3,5-trichloroglutarimide. | |
TR199801087T2 (xx) | 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il | |
SU1269465A1 (ru) | Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов | |
RU2072690C1 (ru) | Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина | |
GR930100094A (el) | Μέ?οδος παρασκευής 1,2,3,9-τετραυδρό-9-με?υλό-3-[(2-με?υλό-1Η-ιμιδαζολ-1-υλο)με?υλό]-4Η-καρβαζολ-4-όνης. | |
FI971170A0 (fi) | Uusi menetelmä 3,4-dihydroksi-5-nitrobentsaldehydin valmistamiseksi | |
AU635400B2 (en) | Intermediates for producing benzo(5,6)cycloheptapyridines | |
PL295060A1 (en) | Method of obtaining novel ethyl 3-(6,6-dimethylobicyclo ]3.1.0¦-hex-trans-3-ilo) butanate |